Amendment 164
Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest
A10-0272/2025 – Tomislav Sokol – Amendments by the committee responsible – separate vote – Am 164
Adopted
- For
- 450
- Against
- 205
- Abstained
- 8
roll-call vote at 12:46 · 68% of votes cast in favour
Roll call requested by Patriots
How the groups voted
A group’s line is the position at least two thirds of its voting MEPs took; otherwise it is shown as Divided. Groups from left to right.
| Group | For | Against | Abstained | of | Line |
|---|---|---|---|---|---|
| The Left | 3 | 35 | 0 | 38 | Against |
| Greens | 50 | 0 | 0 | 50 | For |
| S&D | 76 | 48 | 0 | 124 | Divided |
| Renew | 62 | 5 | 0 | 67 | For |
| EPP | 177 | 4 | 1 | 182 | For |
| ECR | 62 | 10 | 1 | 73 | For |
| Patriots | 7 | 72 | 0 | 79 | Against |
| ESN | 0 | 24 | 0 | 24 | Against |
| No group | 13 | 7 | 6 | 26 | — |
“of” = MEPs of the group who voted. Groups as they are now.
Every MEP
663 MEPs voted. Open a group, or filter above.
The Left 38 MEPs
Greens 50 MEPs
S&D 124 MEPs
Renew 67 MEPs
EPP 182 MEPs
ECR 73 MEPs
Patriots 79 MEPs
ESN 24 MEPs
No group 26 MEPs
“Votes in which an MEP voted differently from their group: on decision pages, against a line at least two thirds of the group took; in loyalty figures, against the position most of the group took.” = voted otherwise than a clear line (two thirds of its votes) of the group they sit in now. MEPs with no vote recorded are not listed.